Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD

References

• AnzuetoA. Impact of exacerbations on COPD. Eur Respir Rev. 2010;19(116):113–118. doi:10.1183/09059180.0000261020956179
   PubMedGoogle Scholar
• BafadhelM, McKennaS, TerryS, et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC21680942
   PubMed Web of Science ®Google Scholar
• WilkinsonTMA, ArisE, BourneS, et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax. 2017;72(10):919–927. doi:10.1136/thoraxjnl-2016-20902328432209
   PubMed Web of Science ®Google Scholar
• DonaldsonGC, SeemungalT, JeffriesDJ, WedzichaJA. Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J. 1999;13(4):844–849. doi:10.1034/j.1399-3003.1999.13d25.x10362051
   PubMed Web of Science ®Google Scholar
• AndersonHR, SpixC, MedinaS, et al. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J. 1997;10(5):1064–1071. doi:10.1183/09031936.97.100510649163648
   PubMed Web of Science ®Google Scholar
• MiravitllesM. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J. 2002;20(Supplement 36):9s–19s. doi:10.1183/09031936.02.00400302
   Web of Science ®Google Scholar
• PouwelsKB, DolkFCK, SmithDRM, RobothamJV, SmieszekT. Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother. 2018;73(suppl_2):19–26. doi:10.1093/jac/dkx50229490060
   PubMed Web of Science ®Google Scholar
• PunekarYS, ShuklaA, MüllerovaH. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65–73. doi:10.2147/COPD.S5441724426781
   PubMed Web of Science ®Google Scholar
• O’NeillJ. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. 2016. HM Gov Welcome Trust UK; 2018.
   Google Scholar
• WilsonR, AnzuetoA, MiravitllesM, et al. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:985–993. doi:10.2147/COPD.S8092626082623
   PubMed Web of Science ®Google Scholar
• VollenweiderD, FreiA, Steurer‐SteyC, Garcia‐AymerichJ, PuhanM. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018;10. doi:10.1002/14651858.CD010257.pub2
   Web of Science ®Google Scholar
• AnthonisenN. Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-1963492164
   PubMed Web of Science ®Google Scholar
• MiravitllesM, MoragasA, HernándezS, BayonaC, LlorC. Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? Chest. 2013;144(5):1571–1577. doi:10.1378/chest.13-051823807094
   PubMed Web of Science ®Google Scholar
• ButlerCC, GillespieD, WhiteP, et al. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med. 2019;381(2):111–120. doi:10.1056/NEJMoa180318531291514
   PubMed Web of Science ®Google Scholar
• BatesJ, FrancisNA, WhiteP, et al. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials. 2017;18(1):442. doi:10.1186/s13063-017-2144-828969667
   PubMed Web of Science ®Google Scholar
• StockleyRA, O’BrienC, PyeA, HillSL. Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD. Chest. 2000;117(6):1638–1645. doi:10.1378/chest.117.6.163810858396
   PubMed Web of Science ®Google Scholar
• TsimogianniAM, PapirisSA, KanavakiS, et al. Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease. Respirology. 2009;14(8):1114–1120. doi:10.1111/j.1440-1843.2009.01615.x19761538
   PubMed Web of Science ®Google Scholar
• PapiA, BellettatoCM, BraccioniF, et al. Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–1121. doi:10.1164/rccm.200506-859OC16484677
   PubMed Web of Science ®Google Scholar
• MiravitllesM, KruesmannF, HaverstockD, PerroncelR, ChoudhriSH, ArvisP. Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. Eur Respir J. 2012;39(6):1354–1360. doi:10.1183/09031936.0004211122034649
   PubMed Web of Science ®Google Scholar
• RaSW, KwonYS, YoonSH, et al. Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(4):1424–1432. doi:10.1111/crj.1267128756637
   PubMed Web of Science ®Google Scholar
• DanielsJMA, de GraaffCS, VlaspolderF, SnijdersD, JansenHM, BoersmaWG. Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2010;16(6):583–588. doi:10.1111/j.1469-0691.2009.02892.x
   PubMed Web of Science ®Google Scholar
• ClarkTW, MedinaM, BathamS, CurranMD, ParmarS, NicholsonKG. C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD. Eur Respir J off J Eur Soc Clin Respir Physiol. 2015;45(1):76–86. doi:10.1183/09031936.00092214
   PubMed Web of Science ®Google Scholar